Article

3D Convolutional Neural Networks for Classification of Alzheimer’s and Parkinson’s Disease with T1-Weighted Brain MRI

2021-07-27

Abstract excerpt

<h4>ABSTRACT</h4> Parkinson’s disease (PD) and Alzheimer’s disease (AD) are progressive neurodegenerative disorders that affect millions of people worldwide. In this work, we propose a deep learning approach to classify these diseases based on 3D T1-weighted brain MRI. We analyzed several datasets including the Parkinson’s Progression Markers Initiative (PPMI), an independent dataset from the University of Pennsy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 48891793-cdf0-50e4-b707-801ce5508264
DOI: 10.1101/2021.07.26.453903

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

3D Convolutional Neural Networks for Classification of Alzheimer’s and Parkinson’s Disease with T1-Weighted Brain MRIDOI 10.1101/2021.07.26.453903Read

Comparison of Anatomical and Diffusion MRI for detecting Parkinson’s Disease using Deep Convolutional Neural NetworkSemantic proximity Read

Differential Diagnosis of Cognitive Disorders using Deep Learning Techniques based on Neuroimaging DataSemantic proximity Read

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imagingSemantic proximity Read

Predicting Dementia Severity by Merging Anatomical and Diffusion MRI with Deep 3D Convolutional Neural NetworksSemantic proximity Read

Multimodal CNN-PD: A Parkinson's Disease Diagnostics Framework Using Multimodal Convolutional Neural NetworkSemantic proximity Read

Advanced Deep Learning Framework for Early Alzheimer’s Disease Classification and Disease MonitoringSemantic proximity Read

Deep learning classification of MRI differentiates brain changes in genetic and idiopathic Parkinson’s diseaseSemantic proximity Read

Explainable 3D CNNs link regional and network level disruption in early Parkinson’s MRIs to symptom progressionSemantic proximity Read

NeuroXNet: Creating A Novel Deep Learning Architecture that Diagnoses Neurological Disorders, Finds New Blood Biomarkers, and Assesses Surgical, Drugs, and Radiation Treatment Plans Using Medical Imaging and Genomic DataSemantic proximity Read

Development and validation of a deep learning framework for Alzheimer’s disease classificationSemantic proximity Read

A Practical Alzheimer Disease Classifier via Brain Imaging-Based Deep Learning on 85,721 SamplesSemantic proximity Read

Activation maps of convolutional neural networks as a tool for brain degeneration tracking in early diagnosis of dementia in Parkinson's disease based on magnetic resonance imagingSemantic proximity Read